Inflammatory Resolution: new opportunities for drug discovery (original) (raw)

• Florey, H. W. General Pathology (Lloyd–Luke Ltd, London, 1970). Provides a fantastic historical perspective of inflammation research as well as detailed accounts of some of the classic experiments that have contributed to our current understanding of the inflammatory response.
  Google Scholar
• Cotran, R. S., Kumar, V. & Collins, T. (eds) in Robbins Pathologic Basis of Disease Vol. 6 50–88 (W. B. Saunders Company, Philadelphia, 1999).
  Google Scholar
• Cotran, R. S., Kumar, V. & Collins, T. (eds) in Robbins Pathologic Basis of Disease Vol. 6 89–112 (W. B. Saunders Company, Philadelphia, 1999).
  Google Scholar
• Dumonde, D. C. & Glynn, L. E. The production of arthritis in rabbits by an immunological reaction to fibrin. Br. J. Exp. Pathol. 43, 373 (1962).
  CAS PubMed PubMed Central Google Scholar
• Dumonde, D. C. & Glynn, L. E. The reaction of guinea-pigs to autologous and heterologous fibrin implants. J. Pathol. Bacteriol. 90, 649–657 (1965).
  CAS PubMed Google Scholar
• Weissmann, G., Becher, G., Wiedermann, G. & Bernheimer, A. W. Studies on lysozymes. VII. Acute and chronic arthritis produced by intra-articular injections of streptolysin 'S' in rabbits. Am. J. Pathol. 46, 129 (1965).
  CAS PubMed PubMed Central Google Scholar
• Willoughby, D. A. & Ryan, G. B. Evidence for a possible endogenous antigen in chronic inflammation. J. Pathol. 101, 233–239 (1970).
  CAS PubMed Google Scholar
• Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocoritcoid-Induced Osteoporosis. Arthritis Rheum. 44, 1496–1503 (2001).
• Beer, H. D., Fassler, R. & Werner, S. Glucocorticoid-regulated gene expression during cutaneous wound repair. Vitam. Horm. 59, 217–239 (2000).
  CAS PubMed Google Scholar
• Mukherjee, D. Selective cyclooxygenase-2 (COX-2) inhibitors and potential risk of cardiovascular events. Biochem. Pharmacol. 63, 817–821 (2002).
  CAS PubMed Google Scholar
• Antoni, C. & Braun, J. Side effects of anti-TNF therapy: current knowledge. Clin. Exp. Rheumatol. 20, S152–S157 (2002).
  CAS PubMed Google Scholar
• Urade, Y. & Hayaishi, O. Prostaglandin D synthase: structure and function. Vitam. Horm. 58, 89–120 (2000).
  CAS PubMed Google Scholar
• Straus, D. S. & Glass, C. K. Cyclopentenone prostaglandins: new insights on biological activities and cellular targets. Med. Res. Rev. 21, 185–210 (2001). This is a comprehensive review of cyclopentenone prostaglandins that covers their synthesis, structure and role in pathophysiology.
  CAS PubMed Google Scholar
• Jiang, C., Ting, A. T. & Seed, B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391, 82–86 (1998).
  CAS PubMed Google Scholar
• Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J. & Glass, C. K. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391, 79–82 (1998). References 14 and 15 report on the receptor-mediated actions of the cyclopentenone prostaglandins that lead to a suppression of inflammation.
  CAS PubMed Google Scholar
• Nosjean, O. & Boutin, J. A. Natural ligands of PPARgamma: are prostaglandin J(2) derivatives really playing the part? Cell Signal. 14, 573–583 (2002).
  CAS PubMed Google Scholar
• Straus, D. S. et al. 15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway. Proc. Natl Acad. Sci. USA 97, 4844–4849 (2000).
  CAS PubMed PubMed Central Google Scholar
• Perez-Sala, D., Cernuda-Morollon, E. & Canada, F. J. Molecular basis for the direct inhibition of AP-1 DNA binding by 15-deoxy-Delta 12,14-prostaglandin J2. J. Biol. Chem. 278, 51251–51260 (2003).
  CAS PubMed Google Scholar
• Chen, C. W., Chang, Y. H., Tsi, C. J. & Lin, W. W. Inhibition of IFN-gamma-mediated inducible nitric oxide synthase induction by the peroxisome proliferator-activated receptor gamma agonist, 15-deoxy-delta 12,14-prostaglandin J2, involves inhibition of the upstream Janus kinase/STAT1 signaling pathway. J. Immunol. 171, 979–988 (2003).
  CAS PubMed Google Scholar
• Maggi, L. B. Jr et al. Anti-inflammatory actions of 15-deoxy-delta 12,14-prostaglandin J2 and troglitazone: evidence for heat shock-dependent and-independent inhibition of cytokine-induced inducible nitric oxide synthase expression. Diabetes 49, 346–355 (2000).
  CAS PubMed Google Scholar
• Petrova, T. V., Akama, K. T. & Van Eldik, L. J. Cyclopentenone prostaglandins suppress activation of microglia: down-regulation of inducible nitric-oxide synthase by 15-deoxy-Delta12,14-prostaglandin J2. Proc. Natl Acad. Sci. USA 96, 4668–4673 (1999).
  CAS PubMed PubMed Central Google Scholar
• Bernardo, A., Levi, G. & Minghetti, L. Role of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) and its natural ligand 15-deoxy-Delta12, 14-prostaglandin J2 in the regulation of microglial functions. Eur. J. Neurosci. 12, 2215–2223 (2000).
  CAS PubMed Google Scholar
• Gosset, P. et al. Prostaglandin D2 affects the maturation of human monocyte-derived dendritic cells: consequence on the polarization of naive Th cells. J. Immunol. 170, 4943–4952 (2003).
  CAS PubMed Google Scholar
• Jackson, S. M. et al. Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction. Arterioscler. Thromb. Vasc. Biol. 19, 2094–2104 (1999).
  CAS PubMed Google Scholar
• Pasceri, V., Wu, H. D., Willerson, J. T. & Yeh, E. T. Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators. Circulation 101, 235–238 (2000).
  CAS PubMed Google Scholar
• Zhang, X., Wang, J. M., Gong, W. H., Mukaida, N. & Young, H. A. Differential regulation of chemokine gene expression by 15-deoxy-delta 12,14 prostaglandin J2. J. Immunol. 166, 7104–7111 (2001).
  CAS PubMed Google Scholar
• Zernecke, A., Erl, W., Fraemohs, L., Lietz, M. & Weber, C. Suppression of endothelial adhesion molecule up-regulation with cyclopentenone prostaglandins is dissociated from IkappaB-alpha kinase inhibition and cell death induction. FASEB J. 17, 1099–1101 (2003).
  CAS PubMed Google Scholar
• Gilroy, D. W., Tomlinson, A. & Willoughby, D. A. Differential effects of inhibitors of cyclooxygenase (cyclooxygenase 1 and cyclooxygenase 2) in acute inflammation. Eur. J. Pharmacol. 355, 211–217 (1998).
  CAS PubMed Google Scholar
• Gilroy, D. W. et al. Inducible cyclooxygenase may have anti-inflammatory properties. Nature Med. 5, 698–701 (1999). This paper originally described the synthesis of anti-inflammatory eicosanoids during acute inflammatory resolution, thereby highlighting that the host actively manufactures soluble mediators to switch off acute inflammation and limit tissue damage.
  CAS PubMed Google Scholar
• Gilroy, D. W., Newson, J., Sawmynaden, P., Willoughby, D. A. & Croxtall, J. D. A novel role for phospholipase A2 isoforms in the checkpoint control of acute inflammation. FASEB J. 18, 489–498 (2004).
  CAS PubMed Google Scholar
• Gilroy, D. W. et al. Inducible cyclooxygenase-derived 15-deoxy(Delta)12-14PGJ2 brings about acute inflammatory resolution in rat pleurisy by inducing neutrophil and macrophage apoptosis. FASEB J. 17, 2269–2271 (2003).
  CAS PubMed Google Scholar
• Ward, C. et al. Prostaglandin D2 and its metabolites induce caspase-dependent granulocyte apoptosis that is mediated via inhibition of I kappa B alpha degradation using a peroxisome proliferator-activated receptor-gamma-independent mechanism. J. Immunol. 168, 6232–6243 (2002).
  CAS PubMed Google Scholar
• Castrillo, A. et al. Potentiation of protein kinase C zeta activity by 15-deoxy-delta(12,14)-prostaglandin J(2) induces an imbalance between mitogen-activated protein kinases and NF-kappaB that promotes apoptosis in macrophages. Mol. Cell Biol. 23, 1196–1208 (2003).
  CAS PubMed PubMed Central Google Scholar
• Li, L. et al. 15-deoxy-delta 12,14-prostaglandin J2 induces apoptosis of human hepatic myofibroblasts. A pathway involving oxidative stress independently of peroxisome-proliferator-activated receptors. J. Biol. Chem. 276, 38152–38158 (2001).
  CAS PubMed Google Scholar
• Reference deleted in proof.
• Setoguchi, K. et al. Peroxisome proliferator-activated receptor-gamma haploinsufficiency enhances B cell proliferative responses and exacerbates experimentally induced arthritis. J. Clin. Invest. 108, 1667–1675 (2001).
  CAS PubMed PubMed Central Google Scholar
• Ando, M. et al. Retrovirally introduced prostaglandin D2 synthase suppresses lung injury induced by bleomycin. Am. J. Respir. Cell. Mol. Biol. 28, 582–591 (2003).
  CAS PubMed Google Scholar
• Cuzzocrea, S. et al. The cyclopentenone prostaglandin 15-deoxy-delta(12,14)-PGJ2 attenuates the development of colon injury caused by dinitrobenzene sulphonic acid in the rat. Br. J. Pharmacol. 138, 678–688 (2003).
  CAS PubMed PubMed Central Google Scholar
• Chatterjee, P. K. et al. The cyclopentenone prostaglandin 15-deoxy-Delta(12,14)-prostaglandin J(2) ameliorates ischemic acute renal failure. Cardiovasc. Res. 61, 630–643 (2004).
  CAS PubMed Google Scholar
• Kawahito, Y. et al. 15-deoxy-delta(12,14)-PGJ(2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats. J. Clin. Invest. 106, 189–197 (2000).
  CAS PubMed PubMed Central Google Scholar
• Diab, A. et al. Peroxisome proliferator-activated receptor-gamma agonist 15-deoxy-delta(12,14)-prostaglandin J(2) ameliorates experimental autoimmune encephalomyelitis. J. Immunol. 168, 2508–2515 (2002).
  CAS PubMed Google Scholar
• Matsuoka, T. et al. Prostaglandin D2 as a mediator of allergic asthma. Science 287, 2013–2017 (2000).
  CAS PubMed Google Scholar
• Honda, K. et al. Prostaglandin D2 reinforces TH2 type inflammatory responses of airways to low-dose antigen through bronchial expression of macrophage-derived chemokine. J. Exp. Med. 198, 533–543 (2003).
  CAS PubMed PubMed Central Google Scholar
• Lee, T. S., Tsai, H. L. & Chau, L. Y. Induction of heme oxygenase-1 expression in murine macrophages is essential for the anti-inflammatory effect of low dose 15-deoxy-delta 12,14-prostaglandin J2. J. Biol. Chem. 278, 19325–19330 (2003).
  CAS PubMed Google Scholar
• Ryter, S. W., Otterbein, L. E., Morse, D. & Choi, A. M. Heme oxygenase/carbon monoxide signaling pathways: regulation and functional significance. Mol. Cell. Biochem. 234–235, 249–263 (2002).
  PubMed PubMed Central Google Scholar
• Willis, D. M. A., Frederick, R. & Willoughby, D. A. Heme oxygenase: a novel target for the modulation of the inflammatory response. Nature Med. 2, 87–90 (1996).
  CAS PubMed Google Scholar
• Graca-Souza, A. V., Arruda, M. A., de Freitas, M. S., Barja-Fidalgo, C. & Oliveira, P. L. Neutrophil activation by heme: implications for inflammatory processes. Blood 99, 4160–4165 (2002).
  CAS PubMed Google Scholar
• Alcaraz, M. J., Fernandez, P. & Guillen, M. I. Anti-inflammatory actions of the heme oxygenase-1 pathway. Curr. Pharm. Des. 9, 2541–2551 (2003).
  CAS PubMed Google Scholar
• Sato, K. et al. Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants. J. Immunol. 166, 4185–4194 (2001).
  CAS PubMed Google Scholar
• Hancock, W. W., Buelow, R., Sayegh, M. H. & Turka, L. A. Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes. Nature Med. 4, 1392–1396 (1998).
  CAS PubMed Google Scholar
• Woo, J., Iyer, S., Mori, N. & Buelow, R. Alleviation of graft-versus-host disease after conditioning with cobalt-protoporphyrin, an inducer of heme oxygenase-1. Transplantation 69, 623–633 (2000).
  CAS PubMed Google Scholar
• Levy, B. D., Clish, C. B., Schmidt, B., Gronert, K. & Serhan, C. N. Lipid mediator class switching during acute inflammation: signals in resolution. Nature Immunol. 2, 612–619 (2001). In addition to reference 25, this paper reinforces the concept of lipid mediator class switching from pro-inflammatory at the onset of acute inflammation to pro-resolving at resolution.
  CAS Google Scholar
• Papayianni, A., Serhan, C. N. & Brady, H. R. Lipoxin A4 and B4 inhibit leukotriene-stimulated interactions of human neutrophils and endothelial cells. J. Immunol. 156, 2264–2272 (1996).
  CAS PubMed Google Scholar
• Serhan, C. N., Takano, T., Clish, C. B., Gronert, K. & Petasis, N. Aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogs inhibit neutrophil-mediated changes in vascular permeability. Adv. Exp. Med. Biol. 469, 287–293 (1999).
  CAS PubMed Google Scholar
• Maddox, J. F. & Serhan, C. N. Lipoxin A4 and B4 are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehydrogenation and reduction. J. Exp. Med. 183, 137–146 (1996).
  CAS PubMed Google Scholar
• Maddox, J. F. et al. Lipoxin A4 stable analogs are potent mimetics that stimulate human monocytes and THP-1 cells via a G-protein-linked lipoxin A4 receptor. J. Biol. Chem. 272, 6972–6978 (1997).
  CAS PubMed Google Scholar
• Jozsef, L., Zouki, C., Petasis, N. A., Serhan, C. N. & Filep, J. G. Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-kappa B and AP-1 activation, and IL-8 gene expression in human leukocytes. Proc. Natl Acad. Sci. USA 99, 13266–13271 (2002).
  CAS PubMed PubMed Central Google Scholar
• Bandeira-Melo, C. et al. Cyclooxygenase-2-derived prostaglandin E2 and lipoxin A4 accelerate resolution of allergic edema in _Angiostrongylus costaricensis_-infected rats: relationship with concurrent eosinophilia. J. Immunol. 164, 1029–1036 (2000).
  CAS PubMed Google Scholar
• Godson, C. et al. Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages. J. Immunol. 164, 1663–1667 (2000).
  CAS PubMed Google Scholar
• Mitchell, S. et al. Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo. J. Am. Soc. Nephrol. 13, 2497–2507 (2002).
  CAS PubMed Google Scholar
• Brink, C. et al. International Union of Pharmacology XXXVII. Nomenclature for leukotriene and lipoxin receptors. Pharmacol. Rev. 55, 195–227 (2003).
  CAS PubMed Google Scholar
• Bandeira-Melo, C. et al. Cutting edge: lipoxin (LX) A4 and aspirin-triggered 15-epi-LXA4 block allergen-induced eosinophil trafficking. J. Immunol. 164, 2267–2271 (2000).
  CAS PubMed Google Scholar
• Serhan, C. N. et al. Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J. Exp. Med. 192, 1197–1204 (2000).
  CAS PubMed PubMed Central Google Scholar
• Serhan, C. N. et al. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J. Exp. Med. 196, 1025–1037 (2002). References 63 and 64 report on the role of aspirin-triggered lipid mediator metabolites of polyunsaturated fatty acids and their spontaneous synthesis during the resolving phase of acute inflammation.
  CAS PubMed PubMed Central Google Scholar
• Hong, S., Gronert, K., Devchand, P. R., Moussignac, R. L. & Serhan, C. N. Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood and glial cells. Autacoids in anti-inflammation. J. Biol. Chem. 278, 14677–14687 (2003).
  CAS PubMed Google Scholar
• Brezinski, D. A., Nesto, R. W. & Serhan, C. N. Angioplasty triggers intracoronary leukotrienes and lipoxin A4. Impact of aspirin therapy. Circulation 86, 56–63 (1992).
  CAS PubMed Google Scholar
• Van Dyke, T. E. & Serhan, C. N. Resolution of inflammation: a new paradigm for the pathogenesis of periodontal diseases. J. Dent. Res. 82, 82–90 (2003).
  CAS PubMed Google Scholar
• Claria, J. et al. Altered biosynthesis of leukotrienes and lipoxins and host defense disorders in patients with cirrhosis and ascites. Gastroenterology 115, 147–156 (1998).
  CAS PubMed Google Scholar
• Levy, B. D. et al. Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A(4). Nature Med. 8, 1018–1023 (2002).
  CAS PubMed Google Scholar
• Munger, K. A. et al. Transfection of rat kidney with human 15-lipoxygenase suppresses inflammation and preserves function in experimental glomerulonephritis. Proc. Natl Acad. Sci. USA 96, 13375–13380 (1999).
  CAS PubMed PubMed Central Google Scholar
• Leonard, M. O. et al. 15-Epi-16-(para-fluorophenoxy)-lipoxin A(4)-methyl ester, a synthetic analogue of 15-epi-lipoxin A(4), is protective in experimental ischemic acute renal failure. J. Am. Soc. Nephrol. 13, 1657–1662 (2002).
  CAS PubMed Google Scholar
• Schottelius, A. J. et al. An aspirin-triggered lipoxin A4 stable analog displays a unique topical anti-inflammatory profile. J. Immunol. 169, 7063–7070 (2002).
  CAS PubMed Google Scholar
• Souza, M. H., de Lima, O. M., Zamuner, S. R., Fiorucci, S. & Wallace, J. L. Gastritis increases resistance to aspirin-induced mucosal injury via COX-2-mediated lipoxin synthesis. Am. J. Physiol. Gastrointest. Liver Physiol. 285, G54–G61 (2003).
  CAS PubMed Google Scholar
• Hughes, J. et al. Neutrophil fate in experimental glomerular capillary injury in the rat. Emigration exceeds in situ clearance by apoptosis. Am. J. Pathol. 150, 223–234 (1997).
  CAS PubMed PubMed Central Google Scholar
• Martin, C. et al. Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence. Immunity 19, 583–593 (2003).
  CAS PubMed Google Scholar
• Bellingan, G. J., Caldwell, H., Howie, S. E., Dransfield, I. & Haslett, C. In vivo fate of the inflammatory macrophage during the resolution of inflammation: inflammatory macrophages do not die locally, but emigrate to the draining lymph nodes. J. Immunol. 157, 2577–2585 (1996).
  CAS PubMed Google Scholar
• Bellingan, G. J. et al. Adhesion molecule-dependent mechanisms regulate the rate of macrophage clearance during the resolution of peritoneal inflammation. J. Exp. Med. 196, 1515–1521 (2002). References 76 and 77 show comprehensively that in resolving peritonitis, the fate of macrophage clearance is through lymphatic drainage.
  CAS PubMed PubMed Central Google Scholar
• Savill, J. & Fadok, V. Corpse clearance defines the meaning of cell death. Nature 407, 784–788 (2000). A concise review highlighting the concept of apoptosis and phagocytosis and their relevance to inflammatory disease processes.
  CAS PubMed Google Scholar
• Nicholson, D. W. From bench to clinic with apoptosis-based therapeutic agents. Nature 407, 810–816 (2000).
  CAS PubMed Google Scholar
• Brunner, T. & Mueller, C. Apoptosis in disease: about shortage and excess. Essays Biochem. 39, 119–130 (2003).
  CAS PubMed Google Scholar
• Fadok, V. A., Bratton, D. L. & Henson, P. M. Phagocyte receptors for apoptotic cells: recognition, uptake, and consequences. J. Clin. Invest. 108, 957–962 (2001).
  CAS PubMed PubMed Central Google Scholar
• Savill, J., Dransfield, I., Gregory, C. & Haslett, C. A blast from the past: clearance of apoptotic cells regulates immune responses. Nature Rev. Immunol. 2, 965–975 (2002).
  CAS Google Scholar
• Ward, C., Dransfield, I., Chilvers, E. R., Haslett, C. & Rossi, A. Pharmacological manipulation of granulocyte apoptosis: potential therapeutic targets. Trends Pharmacol. Sci. 20, 503–509 (1999).
  CAS PubMed Google Scholar
• Giles, K. M., Hart, S. P., Haslett, C., Rossi, A. G. & Dransfield, I. An appetite for apoptotic cells? Controversies and challenges. Br. J. Haematol. 109, 1–12 (2000).
  CAS PubMed Google Scholar
• Rossi, A. G. et al. Regulation of macrophage phagocytosis of apoptotic cells by cAMP. J. Immunol. 160, 3562–3568 (1998).
  CAS PubMed Google Scholar
• Liu, Y. et al. Glucocorticoids promote nonphlogistic phagocytosis of apoptotic leukocytes. J. Immunol. 162, 3639–3646 (1999).
  CAS PubMed Google Scholar
• Giles, K. M. et al. Glucocorticoid augmentation of macrophage capacity for phagocytosis of apoptotic cells is associated with reduced p130Cas expression, loss of paxillin/pyk2 phosphorylation, and high levels of active Rac. J. Immunol. 167, 976–986 (2001).
  CAS PubMed Google Scholar
• Ren, Y. & Savill, J. Proinflammatory cytokines potentiate thrombospondin-mediated phagocytosis of neutrophils undergoing apoptosis. J. Immunol. 154, 2366–2374 (1995).
  CAS PubMed Google Scholar
• McCutcheon, J. C. et al. Regulation of macrophage phagocytosis of apoptotic neutrophils by adhesion to fibronectin. J. Leukoc. Biol. 64, 600–607 (1998).
  CAS PubMed Google Scholar
• Hart, S. P., Dougherty, G. J., Haslett, C. & Dransfield, I. CD44 regulates phagocytosis of apoptotic neutrophil granulocytes, but not apoptotic lymphocytes, by human macrophages. J. Immunol. 159, 919–925 (1997).
  CAS PubMed Google Scholar
• Teder, P. et al. Resolution of lung inflammation by CD44. Science 296, 155–158 (2002).
  CAS PubMed Google Scholar
• Woolley, K. L. et al. Eosinophil apoptosis and the resolution of airway inflammation in asthma. Am. J. Respir. Crit. Care Med. 154, 237–243 (1996).
  CAS PubMed Google Scholar
• Murphy, F. J., Seery, L. T. & Hayes, I. Therapeutic approaches to the modulation of apoptosis. Essays Biochem. 39, 131–153 (2003).
  CAS PubMed Google Scholar
• Degterev, A., Boyce, M. & Yuan, J. A decade of caspases. Oncogene 22, 8543–8567 (2003).
  CAS PubMed Google Scholar
• Earnshaw, W. C., Martins, L. M. & Kaufmann, S. H. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu. Rev. Biochem. 68, 383–424 (1999).
  CAS PubMed Google Scholar
• Graczyk, P. P. Caspase inhibitors as anti-inflammatory and antiapoptotic agents. Prog. Med. Chem. 39, 1–72 (2002).
  CAS PubMed Google Scholar
• Iwata, A., Harlan, J. M., Vedder, N. B. & Winn, R. K. The caspase inhibitor z-VAD is more effective than CD18 adhesion blockade in reducing muscle ischemia-reperfusion injury: implication for clinical trials. Blood 100, 2077–2080 (2002).
  CAS PubMed Google Scholar
• Natori, S., Higuchi, H., Contreras, P. & Gores, G. J. The caspase inhibitor IDN-6556 prevents caspase activation and apoptosis in sinusoidal endothelial cells during liver preservation injury. Liver Transpl. 9, 278–284 (2003).
  PubMed Google Scholar
• Hoglen, N. C. et al. Characterization of IDN-6556: a liver-targeted caspase inhibitor. J. Pharmacol. Exp. Ther. 23 Jan 2004 [epub ahead of print].
• Valentino, K. L., Gutierrez, M., Sanchez, R., Winship, M. J. & Shapiro, D. A. First clinical trial of a novel caspase inhibitor: anti-apoptotic caspase inhibitor, IDN-6556, improves liver enzymes. Int. J. Clin. Pharmacol. Ther. 41, 441–449 (2003).
  CAS PubMed Google Scholar
• Karin, M. New twists in gene regulation by glucocorticoid receptor: is DNA binding dispensable? Cell 93, 487–490 (1998).
  CAS PubMed Google Scholar
• Ghosh, S., May, M. J. & Kopp, E. B. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16, 225–260 (1998).
  CAS PubMed Google Scholar
• Khoshnan, A. et al. The NF-kappa B cascade is important in Bcl-xL expression and for the anti-apoptotic effects of the CD28 receptor in primary human CD4+ lymphocytes. J. Immunol. 165, 1743–1754 (2000).
  CAS PubMed Google Scholar
• Ward, C. et al. NF-kappaB activation is a critical regulator of human granulocyte apoptosis in vitro. J. Biol. Chem. 274, 4309–4318 (1999).
  CAS PubMed Google Scholar
• Lawrence, T., Gilroy, D. W., Colville-Nash, P. R. & Willoughby, D. A. Possible new role for NF-kappaB in the resolution of inflammation. Nature Med. 7, 1291–1297 (2001). Shows an important role for NF-κB in the resolution of acute inflammation that underpins a novel protective role for this otherwise pro-inflammatory factor.
  CAS PubMed Google Scholar
• Ishikawa, H. et al. Chronic inflammation and susceptibility to bacterial infections in mice lacking the polypeptide (p)105 precursor (NF-kappaB1) but expressing p50. J. Exp. Med. 187, 985–996 (1998).
  CAS PubMed PubMed Central Google Scholar
• Bohuslav, J. et al. Regulation of an essential innate immune response by the p50 subunit of NF-kappaB. J. Clin. Invest. 102, 1645–1652 (1998).
  CAS PubMed PubMed Central Google Scholar
• Chen, L. W. et al. The two faces of IKK and NF-kappaB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion. Nature Med. 9, 575–581 (2003).
  CAS PubMed Google Scholar
• Munck, A., Guyre, P. M. & Holbrook, N. J. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr. Rev. 5, 25–44 (1984).
  CAS PubMed Google Scholar
• Flower, R. J., Parente, L., Persico, P. & Salmon, J. A. A comparison of the acute inflammatory response in adrenalectomised and sham-operated rats. Br. J. Pharmacol. 87, 57–62 (1986).
  CAS PubMed PubMed Central Google Scholar
• Perretti, M., Becherucci, C., Scapigliati, G. & Parente, L. The effect of adrenalectomy on interleukin-1 release in vitro and in vivo. Br. J. Pharmacol. 98, 1137–1142 (1989).
  CAS PubMed PubMed Central Google Scholar
• Adcock, I. M. Molecular mechanisms of glucocorticosteroid actions. Pulm. Pharmacol. Ther. 13, 115–126 (2000).
  CAS PubMed Google Scholar
• Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A. & Karin, M. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270, 286–290 (1995).
  CAS PubMed Google Scholar
• Buttgereit, F., Burmester, G. R. & Brand, M. D. Bioenergetics of immune functions: fundamental and therapeutic aspects. Immunol. Today 21, 192–199 (2000).
  CAS PubMed Google Scholar
• Nissen, R. M. & Yamamoto, K. R. The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain. Genes Dev. 14, 2314–2329 (2000).
  CAS PubMed PubMed Central Google Scholar
• Flower, R. J. Eleventh Gaddum memorial lecture. Lipocortin and the mechanism of action of the glucocorticoids. Br. J. Pharmacol. 94, 987–1015 (1988).
  CAS PubMed PubMed Central Google Scholar
• Croxtall, J. D. & Flower, R. J. Lipocortin 1 mediates dexamethasone-induced growth arrest of the A549 lung adenocarcinoma cell line. Proc. Natl Acad. Sci. USA 89, 3571–3575 (1992).
  CAS PubMed PubMed Central Google Scholar
• De Caterina, R. et al. Macrophage-specific eicosanoid synthesis inhibition and lipocortin-1 induction by glucocorticoids. J. Appl. Physiol. 75, 2368–2375 (1993).
  CAS PubMed Google Scholar
• Mancuso, F., Flower, R. J. & Perretti, M. Leukocyte transmigration, but not rolling or adhesion, is selectively inhibited by dexamethasone in the hamster post-capillary venule. Involvement of endogenous lipocortin 1. J. Immunol. 155, 377–386 (1995).
  CAS PubMed Google Scholar
• Perretti, M., Ahluwalia, A., Harris, J. G., Goulding, N. J. & Flower, R. J. Lipocortin-1 fragments inhibit neutrophil accumulation and neutrophil-dependent edema in the mouse. A qualitative comparison with an anti-CD11b monoclonal antibody. J. Immunol. 151, 4306–4314 (1993).
  CAS PubMed Google Scholar
• Gerke, V. & Moss, S. E. Annexins: from structure to function. Physiol. Rev. 82, 331–371 (2002).
  CAS PubMed Google Scholar
• Perretti, M. et al. Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor. Nature Med. 8, 1296–1302 (2002). Demonstrates, for the first time, the biochemical and functional link between endogenous and exogenous annexin-1 and ALX. Experiments of binding, immunoprecipitation and in vivo analyses of PMN recruitment support this novel idea.
  CAS PubMed Google Scholar
• Le, Y., Murphy, P. M. & Wang, J. M. Formyl-peptide receptors revisited. Trends Immunol. 23, 541–548 (2002).
  CAS PubMed Google Scholar
• Perretti, M. & Gavins, F. N. Annexin 1: an endogenous anti-inflammatory protein. News Physiol. Sci. 18, 60–64 (2003).
  CAS PubMed Google Scholar
• Perretti, M. et al. Acute inflammatory response in the mouse: exacerbation by immunoneutralization of lipocortin 1. Br. J. Pharmacol. 117, 1145–1154 (1996).
  CAS PubMed PubMed Central Google Scholar
• Hannon, R. et al. Aberrant inflammation and resistance to glucocorticoids in annexin 1−/− mouse. FASEB J. 17, 253–255 (2003).
  CAS PubMed Google Scholar
• Yang, Y. H. et al. Modulation of inflammation and response to dexamethasone by Annexin 1 in antigen-induced arthritis. Arthritis Rheum. 50, 976–984 (2004). References 126 and 127 were the first studies with the newly generated annexin-1-null mice to confirm the crucial, not redundant, role that this anti-inflammatory protein plays in prolonging the acute inflammatory response as well as in exacerbating joint inflammation in a model of arthritis.
  CAS PubMed Google Scholar
• Perretti, M. The annexin 1 receptor(s): is the plot unravelling? Trends Pharmacol. Sci. 24, 574–579 (2003). A concise review highlighting the opportunities that derive from the identification of the molecular targets that are responsible for annexin-1 actions.
  CAS PubMed Google Scholar
• Hasko, G. & Cronstein, B. N. Adenosine: an endogenous regulator of innate immunity. Trends Immunol. 25, 33–39 (2004).
  CAS PubMed Google Scholar
• Sitkovsky, M. V. Use of the A(2A) adenosine receptor as a physiological immunosuppressor and to engineer inflammation in vivo. Biochem. Pharmacol. 65, 493–501 (2003).
  CAS PubMed Google Scholar
• Cronstein, B. N., Eberle, M. A., Gruber, H. E. & Levin, R. I. Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells. Proc. Natl Acad. Sci. USA 88, 2441–2445 (1991).
  CAS PubMed PubMed Central Google Scholar
• Cronstein, B. N., Naime, D. & Ostad, E. The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. J. Clin. Invest. 92, 2675–2682 (1993).
  CAS PubMed PubMed Central Google Scholar
• Montesinos, M. C. et al. Adenosine A2A or A3 receptors are required for inhibition of inflammation by methotrexate and its analog MX-68. Arthritis Rheum. 48, 240–247 (2003).
  CAS PubMed Google Scholar
• Xaus, J. et al. IFN-gamma up-regulates the A2B adenosine receptor expression in macrophages: a mechanism of macrophage deactivation. J. Immunol. 162, 3607–3614 (1999).
  CAS PubMed Google Scholar
• Hasko, G., Deitch, E. A., Szabo, C., Nemeth, Z. H. & Vizi, E. S. Adenosine: a potential mediator of immunosuppression in multiple organ failure. Curr. Opin. Pharmacol. 2, 440–444 (2002).
  CAS PubMed Google Scholar
• Blackburn, M. R. Too much of a good thing: adenosine overload in adenosine-deaminase-deficient mice. Trends Pharmacol. Sci. 24, 66–70 (2003).
  CAS PubMed Google Scholar
• Catania, A., Gatti, S., Colombo, G. & Lipton, J. M. Targeting melanocortin receptors as a novel strategy to control inflammation. Pharmacol. Rev. 56, 1–29 (2004).
  CAS PubMed Google Scholar
• Fadok, V. A., Bratton, D. L., Frasch, S. C., Warner, M. L. & Henson, P. M. The role of phosphatidylserine in recognition of apoptotic cells by phagocytes. Cell Death Differ. 5, 551–562 (1998).
  CAS PubMed Google Scholar
• Arur, S. et al. Annexin I is an endogenous ligand that mediates apoptotic cell engulfment. Dev. Cell 4, 587–598 (2003).
  CAS PubMed Google Scholar
• Huynh, M. L., Fadok, V. A. & Henson, P. M. Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J. Clin. Invest. 109, 41–50 (2002).
  CAS PubMed PubMed Central Google Scholar
• Blom, A. B., van Lent, P. L., Holthuysen, A. E. & van den Berg, W. B. Skewed balances in regulation of stimulating and inhibitory FC gamma receptors on macrophages of CIA sensitive mice. Inflamm. Res. 50 (Suppl. 3), S155 (2001).
  Google Scholar
• Edenius, C., Haeggstrom, J. & Lindgren, J. A. Transcellular conversion of endogenous arachidonic acid to lipoxins in mixed human platelet-granulocyte suspensions. Biochem. Biophys. Res. Commun. 157, 801–807 (1988).
  CAS PubMed Google Scholar
• Fiore, S. & Serhan, C. N. Formation of lipoxins and leukotrienes during receptor-mediated interactions of human platelets and recombinant human granulocyte/macrophage colony-stimulating factor-primed neutrophils. J. Exp. Med. 172, 1451–1457 (1990).
  CAS PubMed Google Scholar
• Serhan, C. N., Hamberg, M. & Samuelsson, B. Lipoxins: novel series of biologically active compounds formed from arachidonic acid in human leukocytes. Proc. Natl Acad. Sci. USA 81, 5335–5339 (1984).
  CAS PubMed PubMed Central Google Scholar
• Claria, J. & Serhan, C. N. Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. Proc. Natl Acad. Sci. USA 92, 9475–9479 (1995).
  CAS PubMed PubMed Central Google Scholar
• McLoughlin, R. M. et al. Interplay between IFN-gamma and IL-6 signaling governs neutrophil trafficking and apoptosis during acute inflammation. J. Clin. Invest. 112, 598–607 (2003).
  CAS PubMed PubMed Central Google Scholar
• Hurst, S. M. et al. Il-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity 14, 705–714 (2001).
  CAS PubMed Google Scholar
• Rossi, A. et al. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. Nature 403, 103–108 (2000).
  CAS PubMed Google Scholar
• Castrillo, A., Diaz-Guerra, M. J., Hortelano, S., Martin-Sanz, P. & Bosca, L. Inhibition of IkappaB kinase and IkappaB phosphorylation by 15-deoxy-delta(12,14)-prostaglandin J(2) in activated murine macrophages. Mol. Cell. Biol. 20, 1692–1698 (2000).
  CAS PubMed PubMed Central Google Scholar
• Cernuda-Morollon, E., Pineda-Molina, E., Canada, F. J. & Perez-Sala, D. 15-Deoxy-delta 12,14-prostaglandin J2 inhibition of NF-kappaB-DNA binding through covalent modification of the p50 subunit. J. Biol. Chem. 276, 35530–35536 (2001). References 148–150 show that the cyclopentenone prostaglandins have potent inhibitory signalling effects by directly binding to and altering NF-κB activation in addition to their modes of action discussed in references 14 and 15.
  CAS PubMed Google Scholar
• Bell-Parikh, L. C. et al. Biosynthesis of 15-deoxy delta12,14–PGJ2 and the ligation of PPARgamma. J. Clin. Invest. 112, 945–955 (2003).
  CAS PubMed PubMed Central Google Scholar